Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Chimerix hit as lead drug brincidofovir flunks trial

Antiviral failed to meet its objectives in late-stage study

- PMLiVE

KaloBios files for bankruptcy protection

San Francisco biopharma's shares imploded in the wake of Martin Shkreli's arrest

Doctor doctor, where are all the men?

New data show that half of men put off visiting the doctor. Why is this and what can be done to prevent it?

Say Communications

Sanofi reception

Sanofi uses priority review voucher for diabetes combo

LixiLan in race with Xultophy in bid to hit US market first

Actelion HQ Switzerland

Actelion claims first approval for PAH therapy Uptravi

Gains US approval from the FDA for its key pipeline drug

- PMLiVE

Lars Dreiøe joins Sobi in senior quality and compliance role

Moves to the Swedish rare diseases company from Denmark's ALK

- PMLiVE

M3 Europe appoints Helen Parfitt and Grant Irwin

Healthcare technology company boosts its senior team

- PMLiVE

Shkreli fallout claims Turing jobs and KaloBios’ listing

Both firms continue to suffer with job cuts and de-listing from the Nasdaq

- PMLiVE

Boehringer plans €500m biopharma expansion in Austria

New production facility in Vienna will create 400 jobs when it comes online in 2021

- PMLiVE

Nucala price far too high for US market, says ICER

Concludes GlaxoSmithKline's new severe asthma therapy is not value for money

- PMLiVE

Isis renamed Ionis to sidestep militant association

Says the move should avoid any 'distraction' to its business

- PMLiVE

Update: Shkreli resigns as Turing CEO, ousted from KaloBios

Shares in KaloBios had been hit hard when news of his arrest broke

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links